The global canine arthritis treatment market is on the brink of substantial growth, with projections indicating an increase from USD 2.50 billion in 2024 to an impressive USD 3.77 billion by 2034. This robust expansion, driven by a compound annual growth rate (CAGR) of 4.20%, underscores the rising demand for effective arthritis treatments for dogs.
As pet owners become more aware of the challenges faced by their pets suffering from arthritis, the market is experiencing a surge in demand for innovative treatment solutions. Advancements in veterinary medicine, coupled with increased research into novel therapies, are propelling the market forward. These developments are focused on enhancing the quality of life for dogs affected by arthritis, with new treatments offering more targeted and effective solutions.
The market’s upward trajectory reflects a broader shift in the approach to managing arthritis in pets. Veterinary clinics and pet care providers are increasingly investing in specialized treatments, expanding the options available to pet owners. The introduction of new therapies is essential in meeting the growing demand for better management of canine arthritis.
According to FMI, “The increasing awareness among pet owners and advancements in veterinary care are playing a crucial role in the growth of the canine arthritis treatment market. We are committed to supporting the development and availability of cutting-edge treatments that enhance the well-being of dogs worldwide.”
This anticipated growth presents significant opportunities for stakeholders across the veterinary industry. Pharmaceutical companies, research institutions, and veterinary practitioners are expected to play a pivotal role in shaping the future of canine arthritis treatment. With innovation and improved treatment outcomes as key priorities, the market is set to evolve and meet the needs of pet owners seeking better solutions for their furry companions.
As the focus on pet health and well-being continues to rise, the future of canine arthritis treatment looks promising, with new therapies and solutions on the horizon for enhancing the lives of dogs worldwide.
Key Insights from the Market Study:
- The oral segment leads the market with a 70% share in 2024.
- Non-steroidal Anti-inflammatory Drugs (NSAIDs) dominate the market with a 72% share.
- The canine arthritis treatment market is experiencing strong growth across various regions:
- India: CAGR of 5.30% through 2034
- Spain: CAGR of 5.50% through 2034
- Italy: CAGR of 4.90% through 2034
- Australia: CAGR of 4.70% through 2034
- France: CAGR of 4.60% through 2034
Increased Interest in Canine Arthritis Treatment: Explore Our Detailed Report for Key Trends and Insights!
Competitive Landscape:
The canine arthritis treatment market is highly competitive, with major companies investing heavily in research and development to innovate new treatments. Notable players include Boehringer Ingelheim International GmbH, DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, American Regent, Inc., and DSM.
Recent Developments:
- January 2023: TVM introduced DogStem, Europe’s first licensed stem cell therapy for canine osteoarthritis.
- May 2019: Elanco launched Galliprant, a novel treatment targeting the EP4 receptor to reduce pain and inflammation in canine osteoarthritis.
- February 2024: Rejuvenate Bio partnered with a leading animal health company to develop groundbreaking gene therapy for canine osteoarthritis.
Market Segmentation:
- By Treatment: NSAIDs, Opioids, Stem Cell Therapy (Allogeneic and Autologous)
- By Route of Administration: Oral, Injectable
- By Distribution Channel: Veterinary Hospitals & Clinics, Retail Pharmacies, Drug Stores, e-Commerce
- By Region: North America, Latin America, Asia Pacific, Middle East and Africa (MEA), Europe
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
